# OnCo record cantrixil (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cantrixil/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cantrixil" ;
  schema:name "Cantrixil"@en ;
  schema:alternateName "TRX-E-002-1"@en ;
  schema:description "Cantrixil is an experimental medicine from Vivesto being developed for blood cancers. It is at the laboratory stage for acute myeloid leukaemia, where the FDA has given it orphan drug status, after an earlier phase 1 study."@en ;
  schema:url <https://onco.cc/drugs/cantrixil/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.vivesto.com/en/cantrixil/>, <https://www.vivesto.com/en/vivesto-receives-orphan-drug-designation-in-the-u-s-for-cantrixil-in-aml/>, <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1170226> ;
  onco:status "preclinical" ;
  onco:tag "pipeline", "orphan-designation" ;
  onco:modality "Small molecule (cyclodextrin formulation)" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/ovarian/> ;
  onco:companies <https://onco.cc/companies/vivesto/> .